Article
Differences in DNA methylation of HAMP in blood cells predicts the development of type 2 diabetes
8 Jul 2023
Abstract excerpt
OBJECTIVES: Better disease management can be achieved with earlier detection through robust, sensitive, and easily accessible biomarkers. The aim of the current study was to identify novel epigenetic biomarkers determining the risk of type 2 diabetes (T2D). METHODS: Livers of 10-week-old female New Zealand Obese (NZO) mice, slightly differing in their degree of hyperglycemia and liver fat content and thereby in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
